<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04328051</url>
  </required_header>
  <id_info>
    <org_study_id>UBarcelonaOralSurgery2</org_study_id>
    <nct_id>NCT04328051</nct_id>
  </id_info>
  <brief_title>Influence of the Implant-prosthetic Connection in the Marginal Bone Loss and Bacterial Leakage</brief_title>
  <official_title>Influence of the Implant-prosthetic Connection in the Marginal Bone Loss and Bacterial Leakage. A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Barcelona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Barcelona</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study consists in a double-blinded randomized controlled trial which objective is to
      assess the effect of the implant-abutment connection type -external hexagon, internal hexagon
      and conical connection- in the periimplant marginal bone loss in vertical side and the
      bacterial leakage 12 months after prosthesis placement.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Location: This study is going to take place in the Dentistry Hospital of the University of
      Barcelona (Campus of Bellvitge).

      Study subjects: The sample (105 patients) consists of patients with single tooth edentulous
      spaces or posterior maxillary and/or mandible edentulous spaces in need of dental implants
      with screw-retained single fixed crowns. All of them are being properly informed about the
      study according to the Comité Ético (CEIC) del Hospital Odontològic Universitat de Barcelona
      guidelines, and informed consent must be signed prior to the interventions.

      Material: Registration papers for the study, dental implants, surgery material, prosthetic
      components, Florida Probe Software®, Periapical x-rays, computer, Software Stata 14 and
      Software ImageJ®.

      Determinations: Clinical, radiographic and microbiologic measures since implant placement,
      prosthesis placement and 3, 6, 9 and 12 months after it.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 13, 2018</start_date>
  <completion_date type="Anticipated">December 13, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 13, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Active comparator: Ocean E.C.®, Avinent Implant System S.L., Santpedor, Spain. Active comparator: Ocean I.C.®, Avinent Implant System S.L., Santpedor, Spain. Active comparator: Ocean C.C.®, Avinent Implant System S.L., Santpedor, Spain.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Patient will not know the type of connection of his or her implant until the study has finished. Outcome Assessor will be blinded. In the radiographic evaluation the implant-abutment connection will be hidden to assess the marginal bone loss.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Vertical Marginal Bone Loss (VMBL)</measure>
    <time_frame>Since implant placement (Timing 0) through study completion (Timing 5), an average of 1 year.</time_frame>
    <description>Distance in millimetres between the implant platform and the point of the intra-bone defect that is more apical.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vertical Marginal Bone Loss Tax</measure>
    <time_frame>12 months after prosthesis placement.</time_frame>
    <description>Vertical bone loss in millimetres per implant and unit of time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early implant failure</measure>
    <time_frame>Since implant placement (Timing 0) through prosthesis placement (Timing 1).</time_frame>
    <description>Implant with mobility or failure of the osseointegration process before the prosthesis placement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late implant failure</measure>
    <time_frame>Since prosthesis placement (Timing 1) through study completion (Timing 5), an average of 1 year.</time_frame>
    <description>Implant with mobility or failure of the osseointegration process after the prosthesis placement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Probing pocket depth</measure>
    <time_frame>Since prosthesis placement (Timing 1) through study completion (Timing 5), an average of 1 year.</time_frame>
    <description>Distance in millimetres from the gingival margin to the bottom of the periodontal pocket measured with the periodontal probe. Determined in six points per tooth or implant (Buccal: mesial, medial and distal. Palatal or lingual: mesial, medial and distal).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mucosal recession</measure>
    <time_frame>Since prosthesis placement (Timing 1) through study completion (Timing 5), an average of 1 year.</time_frame>
    <description>Distance in millimetres from the cemento-enamel junction of the tooth or from the implant platform to the gingival margin when it is located apically. Determined in six points per tooth or implant (Buccal: mesial, medial and distal. Palatal or lingual: mesial, medial and distal).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mucosal hyperplasia</measure>
    <time_frame>Since prosthesis placement (Timing 1) through study completion (Timing 5), an average of 1 year.</time_frame>
    <description>Distance in millimetres from the gingival margin to the cemento-enamel junction of the tooth or to the implant platform when the gingiva is located more coronal than them. Determined in six points per tooth or implant (Buccal: mesial, medial and distal. Palatal or lingual: mesial, medial and distal).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical attachment level</measure>
    <time_frame>Since prosthesis placement (Timing 1) through study completion (Timing 5), an average of 1 year.</time_frame>
    <description>Probing pocket depth (mm) plus the recession (mm) or probing pocket depth minus the hyperplasia (mm). Determined in six points per tooth or implant (Buccal: mesial, medial and distal. Palatal or lingual: mesial, medial and distal).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>O'Leary plaque index</measure>
    <time_frame>First visit</time_frame>
    <description>Plaque presence in the dentogingival or implantogingival union. Determined in four points per tooth or implant (Buccal: mesial, medial and distal. Palatal or lingual). Expressed as the percentage (%) of tooth or implant surfaces with plaque presence divided with the total of tooth or implant surfaces in mouth and multiplied per 100.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding on probing</measure>
    <time_frame>Since first visit through study completion (Timing 5), an average of 1 year.</time_frame>
    <description>Presence of blood in the gingival margin after determining the probing pocket depth. Determined in six points per tooth or implant (Buccal: mesial, medial and distal. Palatal or lingual: mesial, medial and distal). Expressed as the percentage (%) of tooth or implant surfaces with blood divided with the total of tooth or implant surfaces in mouth and multiplied per 100.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Suppuration on probing</measure>
    <time_frame>Since first visit through study completion (Timing 5), an average of 1 year.</time_frame>
    <description>Presence of purulent material in the gingival margin after determining the probing pocket depth. Determined in six points per tooth or implant (Buccal: mesial, medial and distal. Palatal or lingual: mesial, medial and distal). Expressed as the percentage (%) of tooth or implant surfaces with pus divided with the total of tooth or implant surfaces in mouth and multiplied per 100.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prosthetic complications</measure>
    <time_frame>Since prosthesis placement (Timing 1) through study completion (Timing 5), an average of 1 year.</time_frame>
    <description>Screw (which connects the crown with the implant) fracture or prosthesis fracture, chipping of the ceramic prosthesis, loosening of the screw (which connects the crown with the implant) or any other prosthetic components.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bacterial leakage</measure>
    <time_frame>12 months after prosthesis placement.</time_frame>
    <description>Quantitative PCR in real time to determine the total amount of bacteria and in particular, of 10 pathogenic species: Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Tannerella forsythensis, Treponema denticola, Prevotella intermedia, Peptostreptococcus micros, Fusobacterium nucleatum, Campylobacter rectus, Eikenella corrodens and Candida albicans.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">105</enrollment>
  <condition>Dental Implant</condition>
  <condition>Bone Loss</condition>
  <condition>Bacterial Infections</condition>
  <arm_group>
    <arm_group_label>Ocean E.C.®, Avinent Implant System S.L.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dental implant with geometry adapted to the biologic architecture of the bone, with platform switching with a positive angle and machined surface with micro-threads in the cervical region. Asymmetric and progressive threads in its body with a double thread pitch. Point-ratio geometry on its apical region, Biomimetic Advanced Surface and external hexagon connection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ocean I.C.®, Avinent Implant System S.L.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dental implant with geometry adapted to the biologic architecture of the bone, with platform switching with a positive angle and machined surface with micro-threads in the cervical region. Asymmetric and progressive threads in its body with a double thread pitch. Point-ratio geometry on its apical region, Biomimetic Advanced Surface and internal hexagon connection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ocean C.C.®, Avinent Implant System S.L.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dental implant with geometry adapted to the biologic architecture of the bone, with platform switching with a positive angle and machined surface with micro-threads in the cervical region. Asymmetric and progressive threads in its body with a double thread pitch. Point-ratio geometry on its apical region, Biomimetic Advanced Surface and conical connection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dental Implant Placement</intervention_name>
    <description>Antibiotic prophylaxis will be done. After rinsing with 0.12 % chlorhexidine, patients will receive local anaesthesia. A crestal incision will be done and a mucoperiostic flap will be raised. As the commercial specifies, progressive diameter drills will be used under constant sterile saline irrigation to prepare the implant site. Once finished the drilling sequence, one investigator will open the opaque envelope to know which type of implant, depending on the connection, has to be placed by the surgeon. Dental implant will be placed crestally and depending if it has primary stability or not, it will be leaded submerged or non-submerged. The flap will be repositioned and sutured without tension with 4/0 polyamide. Postoperative instructions and medication will be prescribed and explained.</description>
    <arm_group_label>Ocean C.C.®, Avinent Implant System S.L.</arm_group_label>
    <arm_group_label>Ocean E.C.®, Avinent Implant System S.L.</arm_group_label>
    <arm_group_label>Ocean I.C.®, Avinent Implant System S.L.</arm_group_label>
    <other_name>Surgery</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects who accept signing voluntarily the informed consent before doing any action
             related to the study.

          -  ≥18-years-old patients.

          -  Edentulous single spaces or edentulous posterior maxilla or mandible (from the first
             premolar to the second molar) with screw-retained single fixed crowns.

          -  Single implants successfully osseointegrated placed at least 16 weeks post-extraction.

          -  O'Leary plaque index and or bleeding on probing ≤25%.

          -  Dental implants with screwed-retained prosthesis.

        Exclusion Criteria:

          -  Systemic diseases that can interfere dental implant placement.

          -  Any contraindication for surgery procedures.

          -  Heavy smokers (&gt; 20cig/day).

          -  Background of drug abuse or other factors such as psychiatric diseases that, in
             opinion of the examiner, could interfere with the ability of the patient to cooperate
             and compliment with the study.

          -  Patients who have had participated with another clinical trial the last 30 days.

          -  Pregnant women or in lactation.

          -  Patients with bad oral hygiene or not motivated.

          -  Probing pockets depths with bleeding of ≥4 mm on a tooth adjacent to the edentulous
             space.

          -  Guided bone regeneration required in the same time of the implant placement.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rui Figueiredo, DDS, MS, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eduard Valmaseda-Castellón, DDS, MS, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Octavi Camps-Font, DDS, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roxana Ghiorghiu, DDS, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Laura Rubianes-Porta, DDS, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anna Piñol-Olea, DDS, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Barcelona</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laura Rubianes-Porta, DDS, MS</last_name>
    <phone>+34630873804</phone>
    <email>od074964@uic.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Octavi J. Camps-Font, DDS, MS</last_name>
    <phone>+34665980569</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Barcelona</name>
      <address>
        <city>L'Hospitalet De Llobregat</city>
        <state>Catalunya</state>
        <zip>08903</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Octavi Camps-Font, DDS, MS</last_name>
      <phone>+34665980569</phone>
      <email>occafo@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Rui Figueiredo, DDS, MS, PhD</last_name>
      <phone>+34667378126</phone>
      <email>ruipfigueiredo@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Roxana Ghiorghiu, DDS, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laura Rubianes-Porta, DDS, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anna Piñol-Olea, DDS, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Brånemark PI, Adell R, Breine U, Hansson BO, Lindström J, Ohlsson A. Intra-osseous anchorage of dental prostheses. I. Experimental studies. Scand J Plast Reconstr Surg. 1969;3(2):81-100.</citation>
    <PMID>4924041</PMID>
  </reference>
  <reference>
    <citation>Albrektsson T, Donos N; Working Group 1. Implant survival and complications. The Third EAO consensus conference 2012. Clin Oral Implants Res. 2012 Oct;23 Suppl 6:63-5. doi: 10.1111/j.1600-0501.2012.02557.x. Review.</citation>
    <PMID>23062128</PMID>
  </reference>
  <reference>
    <citation>Derks J, Tomasi C. Peri-implant health and disease. A systematic review of current epidemiology. J Clin Periodontol. 2015 Apr;42 Suppl 16:S158-71. doi: 10.1111/jcpe.12334. Review.</citation>
    <PMID>25495683</PMID>
  </reference>
  <reference>
    <citation>Buser D, Ingimarsson S, Dula K, Lussi A, Hirt HP, Belser UC. Long-term stability of osseointegrated implants in augmented bone: a 5-year prospective study in partially edentulous patients. Int J Periodontics Restorative Dent. 2002 Apr;22(2):109-17.</citation>
    <PMID>12019706</PMID>
  </reference>
  <reference>
    <citation>Albrektsson T, Zarb G, Worthington P, Eriksson AR. The long-term efficacy of currently used dental implants: a review and proposed criteria of success. Int J Oral Maxillofac Implants. 1986 Summer;1(1):11-25. Review.</citation>
    <PMID>3527955</PMID>
  </reference>
  <reference>
    <citation>Oh TJ, Yoon J, Misch CE, Wang HL. The causes of early implant bone loss: myth or science? J Periodontol. 2002 Mar;73(3):322-33. Review.</citation>
    <PMID>11922263</PMID>
  </reference>
  <reference>
    <citation>Quirynen M, Naert I, van Steenberghe D. Fixture design and overload influence marginal bone loss and fixture success in the Brånemark system. Clin Oral Implants Res. 1992 Sep;3(3):104-11.</citation>
    <PMID>1290790</PMID>
  </reference>
  <reference>
    <citation>Malevez C, Hermans M, Daelemans P. Marginal bone levels at Brånemark system implants used for single tooth restoration. The influence of implant design and anatomical region. Clin Oral Implants Res. 1996 Jun;7(2):162-9.</citation>
    <PMID>9002835</PMID>
  </reference>
  <reference>
    <citation>Vidyasagar L, Apse P. Dental implant design and biological effects on bone implant interface. Baltic Dent Maxillofac J. 2004;6:51-4.</citation>
  </reference>
  <reference>
    <citation>Isidor F. Influence of forces on peri-implant bone. Clin Oral Implants Res. 2006 Oct;17 Suppl 2:8-18. Review.</citation>
    <PMID>16968378</PMID>
  </reference>
  <reference>
    <citation>Abrahamsson I, Berglundh T. Effects of different implant surfaces and designs on marginal bone-level alterations: a review. Clin Oral Implants Res. 2009 Sep;20 Suppl 4:207-15. doi: 10.1111/j.1600-0501.2009.01783.x. Review.</citation>
    <PMID>19663966</PMID>
  </reference>
  <reference>
    <citation>Koo KT, Lee EJ, Kim JY, Seol YJ, Han JS, Kim TI, Lee YM, Ku Y, Wikesjö UM, Rhyu IC. The effect of internal versus external abutment connection modes on crestal bone changes around dental implants: a radiographic analysis. J Periodontol. 2012 Sep;83(9):1104-9. doi: 10.1902/jop.2011.110456. Epub 2011 Dec 6.</citation>
    <PMID>22145806</PMID>
  </reference>
  <reference>
    <citation>Nishioka RS, de Vasconcellos LG, de Melo Nishioka GN. Comparative strain gauge analysis of external and internal hexagon, Morse taper, and influence of straight and offset implant configuration. Implant Dent. 2011 Apr;20(2):e24-32. doi: 10.1097/ID.0b013e318211fce8.</citation>
    <PMID>21448016</PMID>
  </reference>
  <reference>
    <citation>Lin MI, Shen YW, Huang HL, Hsu JT, Fuh LJ. A retrospective study of implant-abutment connections on crestal bone level. J Dent Res. 2013 Dec;92(12 Suppl):202S-7S. doi: 10.1177/0022034513510322. Epub 2013 Oct 24.</citation>
    <PMID>24158343</PMID>
  </reference>
  <reference>
    <citation>Astrand P, Engquist B, Dahlgren S, Gröndahl K, Engquist E, Feldmann H. Astra Tech and Brånemark system implants: a 5-year prospective study of marginal bone reactions. Clin Oral Implants Res. 2004 Aug;15(4):413-20.</citation>
    <PMID>15248875</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>June 21, 2018</study_first_submitted>
  <study_first_submitted_qc>March 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 31, 2020</study_first_posted>
  <last_update_submitted>March 27, 2020</last_update_submitted>
  <last_update_submitted_qc>March 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Barcelona</investigator_affiliation>
    <investigator_full_name>Octavi Camps-Font</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Dental Implant</keyword>
  <keyword>Internal Connection</keyword>
  <keyword>External Connection</keyword>
  <keyword>Conical Connection</keyword>
  <keyword>Marginal Bone Loss</keyword>
  <keyword>Implant Prosthetic Connection</keyword>
  <keyword>Bacterial Leakage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bacterial Infections</mesh_term>
    <mesh_term>Bone Diseases, Metabolic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Under request</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

